Results 271 to 280 of about 1,384,630 (286)
Some of the next articles are maybe not open access.
2012
Imaging disease progression in MS is far from straightforward. Markers that may be relevant in the prediction of conversion from RRMS to SPMS may not be of such use when trying to anticipate disability. MRI features that best correlate with current disability may change as the disease advances, and the optimal combination of measures may also differ ...
Declan Chard, David Miller
openaire +1 more source
Imaging disease progression in MS is far from straightforward. Markers that may be relevant in the prediction of conversion from RRMS to SPMS may not be of such use when trying to anticipate disability. MRI features that best correlate with current disability may change as the disease advances, and the optimal combination of measures may also differ ...
Declan Chard, David Miller
openaire +1 more source
Capivasertib delays disease progression
Nature Reviews Clinical Oncology, 2023openaire +2 more sources
Monitoring Disease Progression in Parkinson's Disease
The Journal of Clinical Pharmacology, 2001openaire +2 more sources
Disease progression in Parkinson’s disease
Journal of the Neurological Sciences, 2017Y. Morita +5 more
openaire +1 more source